You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chinese HCV G1

Showing 1 - 25 of 9,570
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Toronto (Intervention Arm, Control Group)

Recruiting
  • Breast Cancer
  • Intervention Arm
  • Control Group
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre, University Health Network
Apr 8, 2022

Extensive-stage Small-cell Lung Cancer Trial in Haikou (Trilaciclib)

Active, not recruiting
  • Extensive-stage Small-cell Lung Cancer
  • Haikou, Hainan, China
    Hainan General Hospital
Jun 13, 2022

Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/pibrentasvir adult formulation, Glecaprevir/pibrentasvir pediatric

Completed
Has Results
  • Hepatitis C Virus (HCV)
  • Glecaprevir/pibrentasvir adult formulation
  • Glecaprevir/pibrentasvir pediatric formulation
  • San Francisco, California
  • +37 more
Sep 19, 2022

Infectious Mononucleosis Trial in Edmonton (traditional Chinese acupuncture, standard medical care)

Terminated
  • Infectious Mononucleosis
  • traditional Chinese acupuncture
  • standard medical care
  • Edmonton, Alberta, Canada
    University of Alberta
Jul 7, 2022

Chronic Hepatitis C Infection Trial in Beijing, Hong Kong (PR4 + LDV/SOF + ASV 4 wk, PR4 + LDV/SOF + SMV 4 wk, PR4 + LDV/SOF +

Recruiting
  • Chronic Hepatitis C Infection
  • PR4 + LDV/SOF + ASV 4 wk
  • +7 more
  • Beijing, Beijing, China
  • +1 more
Aug 27, 2021

Diabetes, Type 1 Trial in China (MiniMed™ 670G insulin pump system)

Completed
  • Diabetes Mellitus, Type 1
  • MiniMed™ 670G insulin pump system
  • Beijing, Beijing, China
  • +3 more
Jun 27, 2021

NSCLC Trial in Shanghai, Hangzhou (D-1553, Other)

Not yet recruiting
  • NSCLC
  • Shanghai, Shanghai, China
  • +1 more
Aug 11, 2022

Advanced or Metastatic Solid Tumor Trial in China (MRTX849)

Recruiting
  • Advanced or Metastatic Solid Tumor
  • Beijing, Beijing, China
  • +9 more
Jun 9, 2022

HER2-positive, Locally Advanced Solid Tumor, Immunotherapy Trial in Beijing (sintilimab, Trastuzumab, S-1 plus oxaliplatin)

Not yet recruiting
  • HER2-positive
  • +6 more
  • Beijing, China
    Cancer Hospital & Institute, Chinese Academy of Medical Sciences
Mar 28, 2022

KRAS P.G12C, NSCLC, Colorectal Cancer Trial in China (JAB-21822, JAB-3312)

Recruiting
  • KRAS P.G12C
  • +3 more
  • Beijing, Beijing, China
  • +23 more
Jun 29, 2022

TESTING -ON Post-Trial ObservatioNal Cohort Study

Not yet recruiting
  • IgA Nephropathy
  • +3 more
    • Kingswood, New South Wales, Australia
    • +59 more
    Jun 21, 2022

    Human Immunodeficiency Virus (HIV), Hepatitis C (HCV) Trial in New York (Video Format, Health Educator)

    Not yet recruiting
    • Human Immunodeficiency Virus (HIV)
    • Hepatitis C (HCV)
    • Video Format
    • Health Educator
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Jul 21, 2023

    Hepatitis C Virus Infection, Response to Therapy of Trial in Canada, United States (Test and treat plus peer mentors, Usual

    Recruiting
    • Hepatitis C Virus Infection, Response to Therapy of
    • Test and treat plus peer mentors
    • Usual care
    • Birmingham, Alabama
    • +3 more
    Dec 9, 2022

    Hepatitis C Trial in Karachi (undefined)

    Recruiting
    • Hepatitis C
    • Karachi, Sindh, Pakistan
      Clinical trials unit
    Feb 10, 2022

    Hepatitis C Trial in Portland, Roseburg (Tele-HCV, Community Linkage to Care)

    Active, not recruiting
    • Hepatitis C
    • Tele-HCV
    • Community Linkage to Care
    • Portland, Oregon
    • +2 more
    Jan 4, 2023

    Hepatocellular Carcinoma, Hepatoma, Liver Cell Carcinoma Trial (Elbasvir / Grazoprevir Oral Tablet)

    Withdrawn
    • Hepatocellular Carcinoma
    • +3 more
    • Elbasvir / Grazoprevir Oral Tablet
    • (no location specified)
    Sep 6, 2020

    Kidney Failure Trial in Loma Linda (Kidney Transplantation)

    Enrolling by invitation
    • Kidney Failure
    • Kidney Transplantation
    • Loma Linda, California
      Loma Linda University Health-Transplant Institute
    Nov 29, 2022

    Liver Cirrhosis Trial in Bunkyo-Ku (Foscenvivint)

    Not yet recruiting
    • Liver Cirrhosis
    • Bunkyo-Ku, Tokyo, Japan
      Tokyo Metropolitan Komagome Hospital
    Nov 29, 2023

    Hepatitis C Virus Trial (Dried blood spot testing)

    Not yet recruiting
    • Hepatitis C Virus
    • Dried blood spot testing
    • (no location specified)
    Mar 5, 2023

    SOF/VEL±RBV: Efficacy and Safety in GT 3 and 6 HCV Patients

    Recruiting
    • Hepatitis C
    • Epclusa (sofosbuvir and velpatasvir)
    • Guangzhou, Guangdong, China
      Deparment of Infectious Diseases, the Second Affiliated Hospital
    Jul 1, 2021

    Hepatitis C, Chronic, Opioid Dependence, on Agonist Therapy Trial in Bergen, Stavanger (Health care delivery)

    Active, not recruiting
    • Hepatitis C, Chronic
    • Opioid Dependence, on Agonist Therapy
    • Health care delivery
    • Bergen, Hordaland, Norway
    • +1 more
    Aug 5, 2022

    Hepatitis C, Chronic Trial (HCV RNA (PCR), HCV Antibody test (Point of care), AST/ALT and platelets measurement)

    Not yet recruiting
    • Hepatitis C, Chronic
    • HCV RNA (PCR)
    • +2 more
    • (no location specified)
    Jun 29, 2021

    Hepatitis C in Prison: Study of Screening and Rapid Treatment

    Not yet recruiting
    • Chronic HIV Infection
    • Xpert® HCV Viral test
    • FibroScan® test
    • Paris, France
      Internal Medicine Service, Cochin Hospital (Consultation and Amb
    Dec 10, 2022

    Hepatitis C Trial in Baltimore (Patient-Centered Electronic App)

    Recruiting
    • Hepatitis C
    • Patient-Centered Electronic App
    • Baltimore, Maryland
      Johns Hopkins University
    Mar 29, 2022

    Diabetic Cardiomyopathies Trial in Worldwide (AT-001, Placebo)

    Active, not recruiting
    • Diabetic Cardiomyopathies
    • Beverly Hills, California
    • +78 more
    Dec 7, 2022